|
TargetMol
clinical stage compounds Clinical Stage Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Clinical+Compound+Library/10__1021_slash_acs__jmedchem__6c01726-423-7-11 Average 95 stars, based on 1 article reviews
clinical stage compounds - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
natural terpenoid compound library ![]() Natural Terpenoid Compound Library, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Compound/pmc13748739-35-1-11 Average 96 stars, based on 1 article reviews
natural terpenoid compound library - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
TargetMol
anti cardiovascular disease compound library ![]() Anti Cardiovascular Disease Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Anti-Cardiovascular+Disease+Compound+Library/pmc13748904-58-22-21 Average 90 stars, based on 1 article reviews
anti cardiovascular disease compound library - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
TargetMol
pharmacopeia compound library ![]() Pharmacopeia Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/FDA-Approved+Drug+Library/10__1038_slash_s41419___026___09401___w-74-10-7 Average 96 stars, based on 1 article reviews
pharmacopeia compound library - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
TargetMol
compound library ![]() Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Clinical+Compound+Library/pm42966158-42-0-11 Average 95 stars, based on 1 article reviews
compound library - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
organoid based drug screening ![]() Organoid Based Drug Screening, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Epigenetics+Compound+Library/pmc13683295-285-4-13 Average 94 stars, based on 1 article reviews
organoid based drug screening - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
TargetMol
drug screen ![]() Drug Screen, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Cell+Cycle+Compound+Library/pm42901431-305-15-20 Average 94 stars, based on 1 article reviews
drug screen - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
TargetMol
endoplasmic reticulum er stress ![]() Endoplasmic Reticulum Er Stress, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Endoplasmic+Reticulum+Stress+Compound+Library/pm42896314-137-3-21 Average 94 stars, based on 1 article reviews
endoplasmic reticulum er stress - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
TargetMol
ferroptosis ![]() Ferroptosis, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Ferroptosis+Compound+Library/pm42896314-137-8-21 Average 96 stars, based on 1 article reviews
ferroptosis - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
TargetMol
acta pharmacologica sinica (2026) 0 ![]() Acta Pharmacologica Sinica (2026) 0, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/compound+library/Bioactive+Compound+Library/pm42875556-80-6-21 Average 97 stars, based on 1 article reviews
acta pharmacologica sinica (2026) 0 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
Journal: JAC-Antimicrobial Resistance
Article Title: Identification of valepotriate as a novel antimycobacterial agent against drug-resistant Mycobacterium tuberculosis through screening of a natural terpenoid compound library
doi: 10.1093/jacamr/dlag250
Figure Lengend Snippet: Primary screening of a terpenoid compound library against M. tb H37Rv. M. tb H37Rv was cultured in Middlebrook 7H9 medium supplemented with OADC and exposed to individual terpenoid compounds at a final concentration of 20 μM for 14 days. Bacterial growth was assessed by OD 600 measurement, and compounds showing marked growth inhibition were identified as primary hits. Untreated bacteria served as the negative control, whereas INH-treated bacteria served as the positive control. Data represent the mean of three independent experiments.
Article Snippet: A
Techniques: Screening, Drug discovery, Cell Culture, Concentration Assay, Inhibition, Bacteria, Negative Control, Positive Control
Journal: Advanced Science
Article Title: Targeting a Calcium‐Associated Mitochondrial Vulnerability in TET2‐Deficient Myeloid Cells
doi: 10.1002/advs.78748
Figure Lengend Snippet: Chemical‐genetic screening identifies Lanatoside C as a selective inhibitor of TET2 ‐KD macrophages. (A) Screening workflow for identifying compounds preferentially targeting TET2‐KD macrophages. siScr and siTET2 THP‐1‐derived macrophages were plated in 384‐well format and treated with 489 compounds from the TargetMol Anti‐Cardiovascular Disease Compound Library for 48 h. Viability was measured by Alamar Blue and normalized to genotype‐matched DMSO controls. Hits were selected based on preservation of siScr viability > 80% and reduction of siTET2 viability < 70%, followed by secondary validation and prioritization of Lanatoside C. (B) Heatmap of relative cell viability in siScr or siTET2 macrophages treated with 489 cardiovascular disease‐related bioactive compounds (10 µM, 48 h). Viability was assessed by Alamar Blue and expressed relative to the corresponding genotype‐matched vehicle controls. n = 4 biologically independent replicates per treatment. (C) Quantification of cell viability by Alamar Blue assay in siScr or siTET2 macrophages treated with vehicle or a subset of 8 selected compounds. n = 8 biologically independent replicates per condition. (D) Quantification of proliferation‐associated metabolic activity using the MTS assay in siScr or siTET2 macrophages treated with vehicle or the same subset of 8 selected compounds. n = 4 biologically independent replicates per condition. (E) Quantification of cleaved‐Caspase‐3‐positive macrophages treated with siScr or siTET2, vehicle (DMSO), or Lanatoside C. n = 4 biologically independent replicates per treatment. (F) Quantification of cell viability by Trypan Blue exclusion in macrophages treated as in (E). n = 4 biologically independent replicates per condition. (G) Quantification of EdU‐positive macrophages treated with siScr or siTET2, vehicle, or Lanatoside C. n = 8 biologically independent replicates per condition. (H–J) Relative IL‐1β, IL‐6, and IL‐18 levels in macrophage monocultures following siScr or siTET2 transfection and treatment with vehicle or Lanatoside C. Cytokines were measured by ELISA and normalized to the siScr Vehicle group. Lanatoside C reduced the elevated inflammatory cytokine levels observed in TET2‐KD macrophages. n = 5 biologically independent replicates per condition. (K) UMAP plots from RNA sequencing of macrophages treated with siScr or siTET2 and vehicle or Lanatoside C. Each biological replicate comprised one million macrophages; n = 3 biologically independent replicates per condition. Data are shown as mean ± SEM. For the quantitative validation experiments in (C‐J), statistical significance was assessed using two‐way ANOVA followed by Tukey's multiple‐comparisons test, with the indicated pairwise comparisons shown in the figure. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
Article Snippet: To identify compounds that preferentially compromise TET2 ‐KD macrophages, we performed chemical‐genetic screening using 489 cardiovascular disease‐related bioactive compounds from the
Techniques: Screening, Derivative Assay, Drug discovery, Preserving, Biomarker Discovery, Alamar Blue Assay, Activity Assay, MTS Assay, Transfection, Enzyme-linked Immunosorbent Assay, RNA Sequencing